The LumiraDx SARS-CoV-2 Ab Test is designed to be used in community care settings to identify individuals with an adaptive immune response to COVID-19, indicating recent or prior infection.
- Easy to implement in point of care settings
Clinical agreement (direct fingerstick) in samples collected more than 8 days post RT-PCR
- 100% (62/62) positive agreement
- 100% (54/54) negative agreement
- Time to result in 11 minutes